Porous Molybdenum Nitride Nanosphere as Carrier-Free and Efficient Nitric Oxide Donor for Synergistic Nitric Oxide and Chemo/Sonodynamic Therapy

Qingchen Bai,Miao Wang,Jingwei Liu,Xilin Sun,Piaoping Yang,Fengyu Qu,Huiming Lin

DOI: https://doi.org/10.1021/acsnano.3c05790

IF: 17.1

2023-10-10

ACS Nano

Abstract:Given its abundant physiological functions, nitric oxide (NO) has attracted much attention as a cancer therapy. The sensitive release and great supply capacity are significant indicators of NO donors and their performance. Here, a transition metal nitride (TMN) MoN@PEG is adopted as an efficient NO donor. The release process starts with H^(+)-triggered denitrogen owing to the high electronegativity of the N atom and weak Mo-N bond. Then, these active NH(x) are oxidized by O(2) and other reactive...

materials science, multidisciplinary,chemistry, physical,nanoscience & nanotechnology

What problem does this paper attempt to address?

The problem this paper attempts to address is the development of an efficient, carrier-free nitric oxide (NO) donor material for cancer therapy. Specifically, the researchers designed porous molybdenum nitride nanospheres (MoN@PEG) that can specifically release NO in the tumor microenvironment and possess peroxidase-mimicking activity and sonosensitization, thereby achieving a synergistic therapeutic effect of NO with chemo/sonodynamic therapy. Below are the main issues and solutions presented in the paper:

### Main Issues:
1. **Controlled Release of NO**: How to achieve specific release of NO in the tumor microenvironment to enhance therapeutic efficacy.
2. **High Supply Capacity of NO**: How to increase the generation of NO to meet therapeutic needs.
3. **Carrier-Free NO Donor**: How to design an NO donor that does not require an additional carrier, simplifying the preparation process and improving atomic utilization.
4. **Multimodal Therapy**: How to combine NO therapy with other treatment methods (such as chemotherapy and sonodynamic therapy) to enhance anticancer effects.

### Solutions:
1. **Porous Structure Design**: Porous molybdenum nitride nanospheres (MoN@PEG) were prepared through a nitrification reaction. Their porous structure not only enhances NO release capacity but also eliminates the need for additional carriers.
2. **Acid Sensitivity**: Utilizing the H+-triggered denitrification process, NO is specifically released in acidic environments, which is characteristic of the tumor microenvironment.
3. **Redox Reactions**: Further promotion of NO generation through oxidation reactions with oxygen and other reactive oxygen species (ROS).
4. **Peroxidase-Mimicking Activity**: MoN@PEG exhibits peroxidase-mimicking activity, generating hydroxyl radicals (·OH) to increase local oxidative stress.
5. **Sonosensitization**: By loading platinum nanoparticles (MoN-Pt@PEG), the effect of sonodynamic therapy is further enhanced, producing more ROS and promoting NO generation.
6. **Biodegradability**: MoN nanospheres gradually degrade during NO release and are eventually excreted from the body through urine and feces, reducing potential side effects.

### Experimental Results:
- **NO Release**: MoN@PEG efficiently releases NO under acidic and H2O2 conditions, with the highest concentration reaching 94.1 ± 5.6 μM.
- **Cytotoxicity**: MoN-Pt@PEG shows significant cytotoxicity in vitro, especially when combined with ultrasound irradiation, resulting in a significant decrease in cell viability.
- **In Vivo Efficacy**: In a mouse model, the MoN-Pt@PEG+US group showed almost complete tumor disappearance with no significant side effects observed.
- **Immune Activation**: Post-treatment, the expression of PD-L1 on the surface of tumor cells was significantly reduced, promoting T cell activation and enhancing the immune response.

In summary, this paper successfully achieved specific NO release and multimodal therapy through the design of porous molybdenum nitride nanospheres, providing new insights and methods for cancer treatment.